120 related articles for article (PubMed ID: 36416415)
1. Impact of mode of training and recertification on ALSFRS-R rater performance.
Hamilton J; Mohan P; Kittle G; Shefner JM
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):289-294. PubMed ID: 36416415
[TBL] [Abstract][Full Text] [Related]
2. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
[No Abstract] [Full Text] [Related]
3. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
[TBL] [Abstract][Full Text] [Related]
4. Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational study.
Meyer T; Spittel S; Grehl T; Weyen U; Steinbach R; Kettemann D; Petri S; Weydt P; Günther R; Baum P; Schlapakow E; Koch JC; Boentert M; Wolf J; Grosskreutz J; Rödiger A; Ilse B; Metelmann M; Norden J; Koc RY; Körtvélyessy P; Riitano A; Walter B; Hildebrandt B; Schaudinn F; Münch C; Maier A
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):175-184. PubMed ID: 35912984
[TBL] [Abstract][Full Text] [Related]
5. Inter-evaluator reliability of the ALS functional rating scale.
Miano B; Stoddard GJ; Davis S; Bromberg MB
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):235-9. PubMed ID: 15799553
[TBL] [Abstract][Full Text] [Related]
6. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
[TBL] [Abstract][Full Text] [Related]
8. The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.
Genge A; Cedarbaum JM; Shefner J; Chio A; Al-Chalabi A; Van Damme P; McDermott C; Glass J; Berry J; van Eijk RPA; Fournier C; Grosskreutz J; Andrews J; Bertone V; Bunte TM; Couillard M; Cummings C; Kittle G; Polzer J; Salmon K; Straub C; van den Berg LH
Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):382-387. PubMed ID: 38396337
[TBL] [Abstract][Full Text] [Related]
9. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R.
Bakker LA; Schröder CD; Tan HHG; Vugts SMAG; van Eijk RPA; van Es MA; Visser-Meily JMA; van den Berg LH
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):75-81. PubMed ID: 31558653
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
[TBL] [Abstract][Full Text] [Related]
12. Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review.
Bhushan NL; Romano CD; Gras-Najjar J; Reno J; Rockwood N; Quattrone W; Adams ET; Kelly B; McLeod L; Bhavnani SP; Bocell FD; Campbell M; Kontson K; Reasner D; Zhang C; Retzky S
Value Health; 2024 May; ():. PubMed ID: 38795957
[TBL] [Abstract][Full Text] [Related]
13. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.
Kaufmann P; Levy G; Montes J; Buchsbaum R; Barsdorf AI; Battista V; Arbing R; Gordon PH; Mitsumoto H; Levin B; Thompson JL;
Amyotroph Lateral Scler; 2007 Feb; 8(1):42-6. PubMed ID: 17364435
[TBL] [Abstract][Full Text] [Related]
14. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
15. Harmonized standard operating procedures for administering the ALS functional rating scale-revised.
Shefner JM; Bunte T; Kittle G; Genge A; van den Berg LH
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):26-33. PubMed ID: 37728307
[TBL] [Abstract][Full Text] [Related]
16. Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures.
Bakers JNE; de Jongh AD; Bunte TM; Kendall L; Han SS; Epstein N; Lavrov A; Beelen A; Visser-Meily JMA; van den Berg LH; van Eijk RPA
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):500-507. PubMed ID: 34949141
[No Abstract] [Full Text] [Related]
17. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
18. Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Malaspina A; Mills R; Tennant A
Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):400-409. PubMed ID: 38426231
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.
Donohue C; Chapin JL; Anderson A; DiBiase L; Gray LT; Wymer JP; Plowman EK
Muscle Nerve; 2023 Sep; 68(3):296-302. PubMed ID: 37345346
[TBL] [Abstract][Full Text] [Related]
20. Utility of the ALSFRS-R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank.
Colvin LE; Foster ZW; Stein TD; Thakore-James M; Salajegheh MK; Carr K; Spencer KR; Abdul Rauf N; Adams L; Averill JG; Walker SE; Robey I; Alvarez VE; Huber BR; McKee AC; Kowall NW; Brady CB
Muscle Nerve; 2022 Aug; 66(2):167-174. PubMed ID: 35585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
